Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 48Arthralgia 3Advanced Breast Cancer 3Polycystic Ovary Syndrome 2Osteoporosis 2Fractures, Bone 2Carcinoma, Intraductal, Noninfiltrating 2Breast Diseases 2Breast Cancer Female 2Sexuality 1Sexual Dysfunctions, Psychological 1Neurotoxicity Syndromes 1Neoplasm Metastasis 1Luminal B/HER2-negative Breast Cancer 1Leiomyoma 1Infertility 1Hormone-receptor-positive Breast Cancer 1Hormone Receptor Positive Breast Carcinoma 1Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1HR+/HER2- Early Breast Cancer 1HR+/HER2+ Early Breast Cancer 1Fatigue 1Estrogen Receptor and/or Progesterone Receptor Positive 1Endometrial Stromal Tumors 1Endometrial Neoplasms 1Bulbo-Spinal Atrophy, X-Linked 1Breast Carcinoma In Situ 1Breast Cancer Metastatic 1Bone Diseases, Metabolic 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Risedronic Acid 4Calcium 4Zoledronic Acid 3Vitamin D 3Radiography, Panoramic 1Nutrition Assessment 1Ibandronic Acid 1Health Promotion 1Geritol 1Exercise Movement Techniques 1Exercise 1Cholecalciferol 1Calcium Carbonate 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Bone Diseases, Metabolic × Aromatase Inhibitors × Clear all
NCT00766532 2012-09-14

Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?

University of Wisconsin, Madison

Phase 4 Completed
12 enrolled 5 charts
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡